基于技术创新能力的生物医药初创企业投资价值评估体系研究

Research on the Investment Value Evaluation System of Biomedical Start up Enterprises Based on Technological Innovation Capability

摘要

在生物医药产业创新加速与资本活跃的大环境下，初创企业依托技术突破和研发能力成为行业变革的重要推动力量。技术创新能力已成为生物医药初创企业获得市场和资本青睐的核心要素，但现有投资价值评估体系对其关注和量化尚不充分。本文系统梳理了生物医药初创企业技术创新能力的内涵，并从技术基础、创新产出、团队建设、产业转化、财务成长等维度，构建以创新能力为核心的投资价值评估体系。通过案例分析和实证验证，研究表明该体系有助于提升高成长性企业的识别精准度、降低投资风险并优化资源配置。文章还提出了动态调整评估指标和完善投后管理的建议，为生物医药投资决策提供理论与实践支持。

Abstract

In the context of accelerated innovation and active capital in the biopharmaceutical industry, startups have become an important driving force for industry change by relying on technological breakthroughs and research and development capabilities. Technological innovation capability has become a core element for biopharmaceutical startups to gain market and capital favor, but the existing investment value evaluation system still lacks sufficient attention and quantification of it. This article systematically summarizes the connotation of the technological innovation capability of biopharmaceutical startups, and constructs an investment value evaluation system with innovation capability as the core from dimensions such as technological foundation, innovation output, team building, industrial transformation, and financial growth. Through case analysis and empirical verification, research has shown that this system helps to improve the accuracy of identifying high growth enterprises, reduce investment risks, and optimize resource allocation. The article also proposes suggestions for dynamically adjusting evaluation indicators and improving post investment management, providing theoretical and practical support for biopharmaceutical investment decisions.

关键词

技术创新能力 / 生物医药初创企业 / 投资价值评估 / 指标体系 / 风险控制

Key words

technological innovation capability / Biomedical startups / Investment value assessment / Indicator system / risk control

参考文献

[1] 刘海涛. 加快发展现代产业体系的生物医药产业——论风险投资对生物医药产业升级的推动效应[J]. 江苏商论, 2025,(07): 96-98+117.

[2] 王子会. 天津市生物医药产业创新发展及对策研究[J]. 天津经济, 2025,(06): 11-13.

[3] 林岑, 熊东帆. 改革助力平台搭桥赋能生物医药创新发展[N]. 厦门日报, 2025-05-22(A02).